5068 Cardiac safety of non-pegylated liposomal doxorubicin in combination with docetaxel as 1st line treatment in locally advanced or metastatic HER2 negative breast cancer (MYOTAX study)

✍ Scribed by L.J.C. van Warmerdam; P.P. Schiphorst; P. Nieboer; M.W. Dercksen; J.F.M. Pruijt; F.E. de Jongh; G.J.M. Creemers

• Book ID: 119600718
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 50 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(09)70960-7